| scholarly article | Q13442814 |
| P50 | author | Michael S. Diamond | Q28051146 |
| Helen M. Lazear | Q37367303 | ||
| P2860 | cites work | A single mutation in chikungunya virus affects vector specificity and epidemic potential | Q21131599 |
| Genetic characterization of Zika virus strains: geographic expansion of the Asian lineage | Q21144503 | ||
| Zika virus. I. Isolations and serological specificity | Q22240545 | ||
| Probable non-vector-borne transmission of Zika virus, Colorado, USA | Q22240615 | ||
| Zika virus outside Africa | Q22241243 | ||
| Genetic and serologic properties of Zika virus associated with an epidemic, Yap State, Micronesia, 2007 | Q22241244 | ||
| Interim Guidelines for Pregnant Women During a Zika Virus Outbreak — United States, 2016 | Q22241494 | ||
| Molecular evolution of Zika virus during its emergence in the 20(th) century | Q22241538 | ||
| Zika virus: a previously slow pandemic spreads rapidly through the Americas | Q22242663 | ||
| Zika Virus in the Americas — Yet Another Arbovirus Threat | Q22248116 | ||
| Zika Virus Outbreak on Yap Island, Federated States of Micronesia | Q22250881 | ||
| Zika virus in Brazil and macular atrophy in a child with microcephaly | Q22330676 | ||
| Inactivation of Zika virus in plasma with amotosalen and ultraviolet A illumination | Q22330681 | ||
| Zika virus intrauterine infection causes fetal brain abnormality and microcephaly: tip of the iceberg? | Q22330682 | ||
| Outbreak of Exanthematous Illness Associated with Zika, Chikungunya, and Dengue Viruses, Salvador, Brazil | Q22330692 | ||
| Potential of selected Senegalese Aedes spp. mosquitoes (Diptera: Culicidae) to transmit Zika virus | Q22330700 | ||
| Pathogen inactivation: emerging indications | Q22330701 | ||
| Zika Virus Outbreak, Bahia, Brazil | Q22330702 | ||
| Zika Virus Transmission from French Polynesia to Brazil | Q22330704 | ||
| Biology of Zika Virus Infection in Human Skin Cells | Q22330706 | ||
| Zika virus: following the path of dengue and chikungunya? | Q22330711 | ||
| Detection of Zika virus in saliva | Q22330713 | ||
| Zika virus infection in a traveller returning to Europe from Brazil, March 2015 | Q22330714 | ||
| First report of autochthonous transmission of Zika virus in Brazil | Q22330715 | ||
| Potential sexual transmission of Zika virus | Q22330722 | ||
| Co-infection with Zika and dengue viruses in 2 patients, New Caledonia, 2014 | Q22330724 | ||
| Detection of Zika virus in urine | Q22330729 | ||
| Concurrent outbreaks of dengue, chikungunya and Zika virus infections – an unprecedented epidemic wave of mosquito-borne viruses in the Pacific 2012–2014 | Q22330735 | ||
| Aedes hensilli as a potential vector of Chikungunya and Zika viruses | Q22330738 | ||
| Complete Coding Sequence of Zika Virus from a French Polynesia Outbreak in 2013 | Q22330741 | ||
| Zika Virus, French Polynesia, South Pacific, 2013 | Q22330743 | ||
| Evidence of perinatal transmission of Zika virus, French Polynesia, December 2013 and February 2014 | Q22330746 | ||
| Potential for Zika virus transmission through blood transfusion demonstrated during an outbreak in French Polynesia, November 2013 to February 2014 | Q22330747 | ||
| Zika virus infection complicated by Guillain-Barre syndrome--case report, French Polynesia, December 2013 | Q22330748 | ||
| Zika virus in Gabon (Central Africa)--2007: a new threat from Aedes albopictus? | Q22330749 | ||
| Zika virus emergence in mosquitoes in southeastern Senegal, 2011 | Q22330757 | ||
| A diagnostic polymerase chain reaction assay for Zika virus | Q22330761 | ||
| Zika virus infection, Cambodia, 2010 | Q22330765 | ||
| Enzyme-Linked Immunosorbent Assays Using Novel Japanese Encephalitis Virus Antigen Improve the Accuracy of Clinical Diagnosis of Flavivirus Infections | Q27486109 | ||
| Dengue virus inoculation to human skin explants: an effective approach to assess in situ the early infection and the effects on cutaneous dendritic cells | Q27486640 | ||
| Are North American Bunyamwera Serogroup Viruses Etiologic Agents of Human Congential Defects of the Central Nervous System? | Q27487582 | ||
| West Nile virus envelope protein glycosylation is required for efficient viral transmission by Culex vectors | Q27489602 | ||
| Microcephaly in north-east Brazil: a retrospective study on neonates born between 2012 and 2015 | Q27927987 | ||
| Oral susceptibility of Singapore Aedes (Stegomyia) aegypti (Linnaeus) to Zika virus | Q22330766 | ||
| Full-length sequencing and genomic characterization of Bagaza, Kedougou, and Zika viruses | Q22330782 | ||
| Sylvatic transmission of arboviruses among Bornean orangutans | Q22330807 | ||
| Yellow fever and Zika virus epizootics and enzootics in Uganda | Q22330854 | ||
| Zika virus infections in Nigeria: virological and seroepidemiological investigations in Oyo State | Q22330859 | ||
| Comparative Studies of some African Arboviruses in Cell Culture and in Mice | Q22330867 | ||
| Isolation of Zika Virus from Aedes Aegypti Mosquitoes in Malaysia * | Q22330876 | ||
| Zika virus infection of the central nervous system of mice | Q22330884 | ||
| Twelve isolations of Zika virus from Aedes (Stegomyia) africanus (Theobald) taken in and above a Uganda forest | Q22330886 | ||
| Zika virus. II. Pathogenicity and physical properties | Q22330899 | ||
| Zika Virus Associated with Microcephaly | Q22683189 | ||
| Guillain-Barré Syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control study | Q23012849 | ||
| Zika Virus Infection Among U.S. Pregnant Travelers — August 2015–February 2016 | Q23024073 | ||
| Molecular evidence of sexual transmission of Ebola virus | Q23922091 | ||
| Phylogeny of Zika Virus in Western Hemisphere, 2015 | Q24047862 | ||
| Detection of Zika Virus in Semen | Q24048084 | ||
| Fatal Sickle Cell Disease and Zika Virus Infection in Girl from Colombia | Q24048653 | ||
| Thrombocytopenia and subcutaneous bleedings in a patient with Zika virus infection | Q24247089 | ||
| Zika virus and microcephaly: why is this situation a PHEIC? | Q24247105 | ||
| Zika virus: Brazil's surge in small-headed babies questioned by report | Q24247125 | ||
| Detection of Autochthonous Zika Virus Transmission in Sincelejo, Colombia | Q24261129 | ||
| Transmission of Zika Virus Through Sexual Contact with Travelers to Areas of Ongoing Transmission — Continental United States, 2016 | Q24261160 | ||
| Update: Interim Guidelines for Health Care Providers Caring for Infants and Children with Possible Zika Virus Infection — United States, February 2016 | Q24261161 | ||
| Local Transmission of Zika Virus — Puerto Rico, November 23, 2015–January 28, 2016 | Q24261162 | ||
| Dengue therapeutics, chemoprophylaxis, and allied tools: state of the art and future directions | Q28542607 | ||
| Zika virus outbreak in the Americas: the need for novel mosquito control methods | Q29035831 | ||
| A structural perspective of the flavivirus life cycle | Q29616269 | ||
| Distinguishing West Nile virus infection using a recombinant envelope protein with mutations in the conserved fusion-loop | Q33638496 | ||
| Both E protein glycans adversely affect dengue virus infectivity but are beneficial for virion release | Q33826834 | ||
| Possible West Nile virus transmission to an infant through breast-feeding--Michigan, 2002. | Q33961875 | ||
| Direct complement restriction of flavivirus infection requires glycan recognition by mannose-binding lectin | Q34089838 | ||
| Host genetic diversity enables Ebola hemorrhagic fever pathogenesis and resistance | Q34445647 | ||
| Ebola RNA Persistence in Semen of Ebola Virus Disease Survivors - Preliminary Report | Q34497945 | ||
| Determinants of attenuation in the envelope protein of the flavivirus Alfuy | Q34630851 | ||
| Case report: probable transmission of vaccine strain of yellow fever virus to an infant via breast milk | Q34634157 | ||
| Isolation of West Nile virus from urine samples of patients with acute infection | Q35035809 | ||
| Keratinocytes are cell targets of West Nile virus in vivo | Q35076652 | ||
| Chikungunya virus: evolution and genetic determinants of emergence | Q35240173 | ||
| Dengue viruses are enhanced by distinct populations of serotype cross-reactive antibodies in human immune sera | Q35294150 | ||
| Molecular genetics of human primary microcephaly: an overview. | Q35624539 | ||
| A new class of highly potent, broadly neutralizing antibodies isolated from viremic patients infected with dengue virus | Q35654743 | ||
| The genome architecture of the Collaborative Cross mouse genetic reference population | Q35748258 | ||
| Genome Wide Identification of SARS-CoV Susceptibility Loci Using the Collaborative Cross | Q35801738 | ||
| Notes from the Field : Evidence of Zika Virus Infection in Brain and Placental Tissues from Two Congenitally Infected Newborns and Two Fetal Losses — Brazil, 2015 | Q24261163 | ||
| Update: Interim Guidelines for Health Care Providers Caring for Pregnant Women and Women of Reproductive Age with Possible Zika Virus Exposure — United States, 2016 | Q24261164 | ||
| Interim Guidelines for Prevention of Sexual Transmission of Zika Virus — United States, 2016 | Q24261165 | ||
| Possible Association Between Zika Virus Infection and Microcephaly — Brazil, 2015 | Q24261167 | ||
| Zika Virus Infection and Stillbirths: A Case of Hydrops Fetalis, Hydranencephaly and Fetal Demise | Q24261185 | ||
| Zika Virus: Diagnostics for an Emerging Pandemic Threat | Q24261249 | ||
| Intrauterine West Nile virus infection--New York, 2002 | Q24276213 | ||
| Birth outcomes following West Nile Virus infection of pregnant women in the United States: 2003-2004 | Q24276215 | ||
| Zika Virus Spreads to New Areas - Region of the Americas, May 2015-January 2016 | Q24286939 | ||
| Value of Routine Dengue Diagnostic Tests in Urine and Saliva Specimens | Q24288750 | ||
| Ecuador Paraiso Escondido Virus, a New Flavivirus Isolated from New World Sand Flies in Ecuador, Is the First Representative of a Novel Clade in the Genus Flavivirus | Q24289057 | ||
| Ocular Findings in Infants With Microcephaly Associated With Presumed Zika Virus Congenital Infection in Salvador, Brazil | Q24291027 | ||
| Detection and sequencing of Zika virus from amniotic fluid of fetuses with microcephaly in Brazil: a case study | Q24311332 | ||
| Neutralizing antibodies against certain viruses in the sera of residents of India | Q24471304 | ||
| Microcephaly in Brazil: how to interpret reported numbers? | Q24574389 | ||
| Flavivirus genome organization, expression, and replication | Q24575500 | ||
| The global distribution and burden of dengue | Q24628768 | ||
| Reemergence of chikungunya virus | Q24701780 | ||
| Molecular Insight into Dengue Virus Pathogenesis and Its Implications for Disease Control | Q26314452 | ||
| Measuring head circumference: Update on infant microcephaly | Q26778549 | ||
| History of domestication and spread of Aedes aegypti--a review | Q26852925 | ||
| Fever versus fever: the role of host and vector susceptibility and interspecific competition in shaping the current and future distributions of the sylvatic cycles of dengue virus and yellow fever virus | Q26864533 | ||
| Inflammatory neuropathies: pathology, molecular markers and targets for specific therapeutic intervention | Q27322544 | ||
| Envelope protein glycosylation status influences mouse neuroinvasion phenotype of genetic lineage 1 West Nile virus strains | Q27469847 | ||
| N-Linked Glycosylation of West Nile Virus Envelope Proteins Influences Particle Assembly and Infectivity | Q27472669 | ||
| Development of a humanized monoclonal antibody with therapeutic potential against West Nile virus | Q27473186 | ||
| Essential Role of Dengue Virus Envelope Protein N Glycosylation at Asparagine-67 during Viral Propagation | Q27480927 | ||
| Recombinant Envelope-Proteins with Mutations in the Conserved Fusion Loop Allow Specific Serological Diagnosis of Dengue-Infections | Q35840849 | ||
| Vector-free transmission and persistence of Japanese encephalitis virus in pigs | Q35931712 | ||
| Virus-induced congenital malformations in cattle | Q36088187 | ||
| Suppression of Drug Resistance in Dengue Virus | Q36431588 | ||
| Targeting host factors to treat West Nile and dengue viral infections | Q37611829 | ||
| West Nile virus infection and immunity | Q38074266 | ||
| Secondary infection as a risk factor for dengue hemorrhagic fever/dengue shock syndrome: an historical perspective and role of antibody-dependent enhancement of infection | Q38087545 | ||
| Congenital cytomegalovirus infection in pregnancy: a review of prevalence, clinical features, diagnosis and prevention. | Q38590590 | ||
| Paradoxical role of antibodies in dengue virus infections: considerations for prophylactic vaccine development | Q38636217 | ||
| N-linked glycan in tick-borne encephalitis virus envelope protein affects viral secretion in mammalian cells, but not in tick cells | Q39130917 | ||
| Zika virus infections in three travellers returning from South America and the Caribbean respectively, to Montpellier, France, December 2015 to January 2016. | Q39214994 | ||
| Dengue virus NS1 protein activates cells via Toll-like receptor 4 and disrupts endothelial cell monolayer integrity | Q40140011 | ||
| Dengue virus NS1 triggers endothelial permeability and vascular leak that is prevented by NS1 vaccination | Q40140017 | ||
| Fatal West Nile virus infection after probable transfusion-associated transmission--Colorado, 2012. | Q40238754 | ||
| Excretion of West Nile virus in urine during acute infection | Q40242372 | ||
| Breast milk as a possible route of vertical transmission of dengue virus? | Q40251552 | ||
| Dengue virus replication in infected human keratinocytes leads to activation of antiviral innate immune responses | Q40319774 | ||
| Evaluation and treatment of hematospermia | Q40371901 | ||
| Associations between West Nile virus infection and symptoms reported by blood donors identified through nucleic acid test screening | Q40391646 | ||
| West Nile virus infection among pregnant women in a northern Colorado community, 2003 to 2004. | Q40484950 | ||
| Single amino acid codon changes detected in louping ill virus antibody-resistant mutants with reduced neurovirulence | Q41556305 | ||
| Cytomegalovirus-induced brain malformations in fetuses | Q41930828 | ||
| Viral envelope protein glycosylation is a molecular determinant of the neuroinvasiveness of the New York strain of West Nile virus | Q42988971 | ||
| West Nile virus in 2006 and 2007: the Canadian Blood Services' experience | Q42993907 | ||
| Guillain-Barré syndrome. | Q51630845 | ||
| Rubella | Q54196648 | ||
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | virus | Q808 |
| Western Hemisphere | Q181982 | ||
| Zika virus | Q202864 | ||
| congenital Zika virus infection | Q27108236 | ||
| P1104 | number of pages | 12 | |
| P5008 | on focus list of Wikimedia project | WikiProject Zika Corpus | Q54439832 |
| P304 | page(s) | 4864-4875 | |
| P577 | publication date | 2016-03-09 | |
| 2016-05-15 | |||
| P1433 | published in | Journal of Virology | Q1251128 |
| P1476 | title | Zika Virus: New Clinical Syndromes and Its Emergence in the Western Hemisphere | |
| P478 | volume | 90 |
| Q51336602 | A Fluorescent Cell-Based System for Imaging Zika Virus Infection in Real-Time. |
| Q24261408 | A Mouse Model of Zika Virus Pathogenesis |
| Q40051279 | A Mouse Model of Zika Virus Sexual Transmission and Vaginal Viral Replication |
| Q28804119 | A Mutation Identified in Neonatal Microcephaly Destabilizes Zika Virus NS1 Assembly in Vitro |
| Q62485399 | A Vesicular Stomatitis Virus-Based Vaccine Carrying Zika Virus Capsid Protein Protects Mice from Viral Infection |
| Q56341869 | A Zika virus vaccine expressing premembrane-envelope-NS1 polyprotein |
| Q94479669 | A conformation-based intra-molecular initiation factor identified in the flavivirus RNA-dependent RNA polymerase |
| Q28954560 | A novel Zika virus mouse model reveals strain specific differences in virus pathogenesis and host inflammatory immune responses |
| Q52565508 | A novel sheet-like virus particle array is a hallmark of Zika virus infection. |
| Q54558051 | A recombinant virus vaccine that protects against both Chikungunya and Zika virus infections. |
| Q28579171 | A structural view of the RNA-dependent RNA polymerases from the Flavivirus genus |
| Q49725222 | Advances in Diagnosis, Surveillance, and Monitoring of Zika Virus: An Update. |
| Q62485332 | Advances in Zika Virus⁻Host Cell Interaction: Current Knowledge and Future Perspectives |
| Q90482709 | An optimized purified inactivated Zika vaccine provides sustained immunogenicity and protection in cynomolgus macaques |
| Q26694337 | An ultrasensitive electrogenerated chemiluminescence-based immunoassay for specific detection of Zika virus |
| Q92894879 | Analysis of the spatial distribution of cases of Zika virus infection and congenital Zika virus syndrome in a state in the southeastern region of Brazil: Sociodemographic factors and implications for public health |
| Q98174612 | Antibiotic fidaxomicin is an RdRp inhibitor as a potential new therapeutic agent against Zika virus |
| Q100736905 | Antibodies targeting epitopes on the cell-surface form of NS1 protect against Zika virus infection during pregnancy |
| Q28827957 | Antibody responses to Zika virus infections in flavivirus-endemic environments |
| Q27468836 | Antiviral Activity of a Novel Compound CW-33 against Japanese Encephalitis Virus through Inhibiting Intracellular Calcium Overload |
| Q52605980 | Antiviral effects of ferric ammonium citrate. |
| Q43046840 | Assessing Zika virus replication and the development of Zika-specific antibodies after a mid-gestation viral challenge in guinea pigs |
| Q59349637 | Basics of memory B-cell responses: lessons from and for the real world |
| Q24570070 | Bioinformatic analysis reveals the expression of unique transcriptomic signatures in Zika virus infected human neural stem cells |
| Q30394327 | CD4+ and CD8+ T-cell immunity to Dengue - lessons for the study of Zika virus |
| Q47552139 | Cellular and Humoral Immunity Protect against Vaginal Zika Virus Infection in Mice |
| Q45324326 | Characterization of large and small-plaque variants in the Zika virus clinical isolate ZIKV/Hu/S36/Chiba/2016. |
| Q40055117 | Characterization of the contemporary Zika virus in immunocompetent mice |
| Q90226047 | Chasing Intracellular Zika Virus Using Proteomics |
| Q43046702 | Comparative analysis of different cell systems for Zika virus (ZIKV) propagation and evaluation of anti-ZIKV compounds in vitro |
| Q56342856 | Comparing the effectiveness of different strains of Wolbachia for controlling chikungunya, dengue fever, and zika |
| Q26484330 | Complete Genome Sequences of Three Historically Important, Spatiotemporally Distinct, and Genetically Divergent Strains of Zika Virus: MR-766, P6-740, and PRVABC-59 |
| Q55711911 | Complete Genome Sequences of Zika Virus Strains Used for the Formulation of CBER/FDA RNA Reference Reagents and Lot Release Panels for Nucleic Acid Technology Testing. |
| Q51336121 | Conflict in the Intracellular Lives of Endosymbionts and Viruses: A Mechanistic Look at Wolbachia-Mediated Pathogen-blocking. |
| Q60949226 | Contemporary Zika Virus Isolates Induce More dsRNA and Produce More Negative-Strand Intermediate in Human Astrocytoma Cells |
| Q64979406 | Convalescent patient-derived monoclonal antibodies targeting different epitopes of E protein confer protection against Zika virus in a neonatal mouse model. |
| Q58671999 | Cross-Reactive Dengue Virus Antibodies Augment Zika Virus Infection of Human Placental Macrophages |
| Q57486493 | Cross-Reactivity and Anti-viral Function of Dengue Capsid and NS3-Specific Memory T Cells Toward Zika Virus |
| Q98232200 | Crystal structures of full length DENV4 NS2B-NS3 reveal the dynamic interaction between NS2B and NS3 |
| Q27869764 | Dampened antiviral immunity to intravaginal exposure to RNA viral pathogens allows enhanced viral replication |
| Q26247258 | Dengue Virus Envelope Dimer Epitope Monoclonal Antibodies Isolated from Dengue Patients Are Protective against Zika Virus |
| Q61795493 | Dengue Virus Immunity Increases Zika Virus-Induced Damage during Pregnancy |
| Q28577861 | Dengue and Zika viruses: lessons learned from the similarities between these Aedes mosquito-vectored arboviruses |
| Q24737245 | Dengue virus sero-cross-reactivity drives antibody-dependent enhancement of infection with zika virus |
| Q61795486 | Detection of Zika virus in mouse mammary gland and breast milk |
| Q47558158 | Development of Antibody Therapeutics against Flaviviruses |
| Q38156855 | Development of Virus like Particle Vaccine and Reporter Assay for Zika Virus |
| Q30145632 | Development of a S-adenosylmethionine analog that intrudes the RNA-cap binding site of Zika methyltransferase |
| Q63246230 | Development of a fluorescence-based method for the rapid determination of Zika virus polymerase activity and the screening of antiviral drugs |
| Q56000964 | Development of a novel peptide aptamer-based immunoassay to detect Zika virus in serum and urine |
| Q47269331 | Development of envelope protein antigens to serologically differentiate Zika from dengue virus infection |
| Q50207356 | Development of vaccines against Zika virus. |
| Q63739941 | Differential human antibody repertoires following Zika infection and the implications for serodiagnostics and disease outcome |
| Q64250610 | Discovery and Computational Analyses of Novel Small Molecule Zika Virus Inhibitors |
| Q30395163 | Efficacy of the broad-spectrum antiviral compound BCX4430 against Zika virus in cell culture and in a mouse model |
| Q92867102 | Efficient transplacental IgG transfer in women infected with Zika virus during pregnancy |
| Q27928015 | Emergence and Spreading Potential of Zika Virus |
| Q40044232 | Emerging Infections and Pertinent Infections Related to Travel for Patients with Primary Immunodeficiencies. |
| Q59245629 | Epidemiology of dengue and other arboviruses in a cohort of school children and their families in Yucatan, Mexico: Baseline and first year follow-up |
| Q58098898 | Evidence of natural Zika virus infection in neotropical non-human primates in Brazil |
| Q92662816 | Expression, Purification, and Characterization of Anti-Zika virus Envelope Protein: Polyclonal and Chicken-Derived Single Chain Variable Fragment Antibodies |
| Q26252232 | Extended surface for membrane association in Zika virus NS1 structure |
| Q50051418 | Favipiravir and Ribavirin Inhibit Replication of Asian and African Strains of Zika Virus in Different Cell Models. |
| Q28222114 | Flavivirus Infection Uncouples Translation Suppression from Cellular Stress Responses |
| Q91779720 | Flavivirus Nonstructural Protein NS5 Dysregulates HSP90 to Broadly Inhibit JAK/STAT Signaling |
| Q45323977 | Full-Length Genome Sequence of Japanese Encephalitis Virus Strain FC792, Isolated from Guangxi, China |
| Q56341104 | Functional Genomics and Immunologic Tools: The Impact of Viral and Host Genetic Variations on the Outcome of Zika Virus Infection |
| Q66679592 | Genome-wide Integrative Analysis of Zika-Virus-Infected Neuronal Stem Cells Reveals Roles for MicroRNAs in Cell Cycle and Stemness |
| Q89997679 | Genomic epidemiological characteristics of dengue fever in Guangdong province, China from 2013 to 2017 |
| Q30145573 | Genomic epidemiology reveals multiple introductions of Zika virus into the United States |
| Q40037502 | Gestational Stage and IFN-λ Signaling Regulate ZIKV Infection In Utero |
| Q90000423 | Glycosylated diphyllin as a broad-spectrum antiviral agent against Zika virus |
| Q24289683 | Highly diversified Zika viruses imported to China, 2016 |
| Q52583331 | History of Mosquitoborne Diseases in the United States and Implications for New Pathogens. |
| Q30145565 | Host response: Cross-fit T cells battle Zika virus |
| Q47250288 | Human T cell responses to Dengue and Zika virus infection compared to Dengue/Zika coinfection |
| Q63248442 | Human antibody response to Zika targets type-specific quaternary structure epitopes |
| Q84957535 | Hydroxycarboxylic Acid Receptor 2 Is a Zika Virus Restriction Factor That Can Be Induced by Zika Virus Infection Through the IRE1-XBP1 Pathway |
| Q24706780 | Identification of Zika Virus and Dengue Virus Dependency Factors using Functional Genomics |
| Q28950660 | Identification of Zika virus epitopes reveals immunodominant and protective roles for dengue virus cross-reactive CD8+ T cells |
| Q100427968 | Identification of a pocket factor that is critical to Zika virus assembly |
| Q38158247 | Immunization of Zika virus envelope protein domain III induces specific and neutralizing immune responses against Zika virus |
| Q63248468 | Immunogenicity and protection conferred by an optimized purified inactivated Zika vaccine in mice |
| Q55084384 | Immunoprofiles of human Sertoli cells infected with Zika virus reveals unique insights into host-pathogen crosstalk. |
| Q55669574 | In Silico Designed Axl Receptor Blocking Drug Candidates Against Zika Virus Infection. |
| Q66679794 | Increased growth ability and pathogenicity of American- and Pacific-subtype Zika virus (ZIKV) strains compared with a Southeast Asian-subtype ZIKV strain |
| Q56347747 | Inflammation-Induced, STING-Dependent Autophagy Restricts Zika Virus Infection in the Drosophila Brain |
| Q60907556 | Interferon lambda protects the female reproductive tract against Zika virus infection |
| Q51336841 | Karyopherin alpha6 Is Required for the Replication of Porcine Reproductive and Respiratory Syndrome Virus and Zika Virus. |
| Q29051494 | Lack of Durable Cross-Neutralizing Antibodies Against Zika Virus from Dengue Virus Infection |
| Q92449663 | Longitudinal analysis of the antibody repertoire of a Zika virus-infected patient revealed dynamic changes in antibody response |
| Q90287815 | Low expression of RNA sensors impacts Zika virus infection in the lower female reproductive tract |
| Q56000942 | Mapping Putative B-Cell Zika Virus NS1 Epitopes Provides Molecular Basis for Anti-NS1 Antibody Discrimination between Zika and Dengue Viruses |
| Q28223043 | Mapping and Role of the CD8+ T Cell Response During Primary Zika Virus Infection in Mice |
| Q38157219 | Mitigation of the threat posed to transfusion by donors traveling to Zika-affected areas: a Canadian risk-based approach |
| Q40049416 | Modified mRNA Vaccines Protect against Zika Virus Infection |
| Q54217627 | Modulation of Dengue/Zika Virus Pathogenicity by Antibody-Dependent Enhancement and Strategies to Protect Against Enhancement in Zika Virus Infection. |
| Q28577785 | Molecular and cellular insights into Zika virus-related neuropathies |
| Q90195807 | Mouse Models as Resources for Studying Infectious Diseases |
| Q28655823 | Multiple introductions of Zika virus into the United States revealed through genomic epidemiology |
| Q45324805 | Multiplexed biomarker panels discriminate Zika and Dengue virus infection in humans |
| Q64055456 | Multiplexed kit based on Luminex technology and achievements in synthetic biology discriminates Zika, chikungunya, and dengue viruses in mosquitoes |
| Q49791115 | N-glycosylation of Viral E Protein Is the Determinant for Vector Midgut Invasion by Flaviviruses. |
| Q26247567 | Navigating the Zika panic |
| Q27927995 | Neurological manifestations of Zika virus infection |
| Q28223446 | Neuropathogenesis of Zika Virus in a Highly Susceptible Immunocompetent Mouse Model after Antibody Blockade of Type I Interferon |
| Q26247171 | Neuroteratogenic Viruses and Lessons for Zika Virus Models |
| Q41919737 | Neutralization of Zika virus by germline-like human monoclonal antibodies targeting cryptic epitopes on envelope domain III. |
| Q47558305 | Nonhuman Primate Models of Zika Virus Infection, Immunity, and Therapeutic Development |
| Q56338862 | Novel genetically stable infectious clone for a Zika virus clinical isolate and identification of RNA elements essential for virus production |
| Q92632493 | Obstetric Ultrasonography to Detect Fetal Abnormalities in a Mouse Model for Zika Virus Infection |
| Q47558388 | Ontogeny of the B- and T-cell response in a primary Zika virus infection of a dengue-naïve individual during the 2016 outbreak in Miami, FL. |
| Q60487631 | Optimization of Zika virus envelope protein production for ELISA and correlation of antibody titers with virus neutralization in Mexican patients from an arbovirus endemic region |
| Q38558860 | Origin of the Zika virus revealed: a historical journey across the world |
| Q38158304 | Pathophysiological mechanisms of Flavivirus infection of the central nervous system |
| Q56341199 | Persistent detection of Zika virus RNA from an infant with severe microcephaly - a case report |
| Q38157816 | Plant-produced Zika virus envelope protein elicits neutralizing immune responses that correlate with protective immunity against Zika virus in mice |
| Q63740112 | Potent Inhibition of Zika Virus Replication by Aurintricarboxylic Acid |
| Q39025905 | Potential for treatment and a Zika virus vaccine |
| Q45324741 | Preconceptual Zika virus asymptomatic infection protects against secondary prenatal infection. |
| Q26247786 | Predicted protein interactions of IFITMs which inhibit Zika virus infection |
| Q55334036 | Proteomic Analysis of Zika Virus Infected Primary Human Fetal Neural Progenitors Suggests a Role for Doublecortin in the Pathological Consequences of Infection in the Cortex. |
| Q51336164 | Rapid response to an emerging infectious disease - Lessons learned from development of a synthetic DNA vaccine targeting Zika virus. |
| Q92689707 | Rational Design of Zika Virus Subunit Vaccine with Enhanced Efficacy |
| Q43046972 | Replication of early and recent Zika virus isolates throughout mouse brain development |
| Q58504680 | Reviews of Science for Science Librarians: The Challenge of the Zika Virus: An Emerging Arbovirus Disease |
| Q38156701 | Ribavirin inhibits Zika virus (ZIKV) replication in vitro and suppresses viremia in ZIKV-infected STAT1-deficient mice |
| Q60031610 | Routes of Zika virus dissemination in the testis and epididymis of immunodeficient mice |
| Q28595153 | Screening Bioactives Reveals Nanchangmycin as a Broad Spectrum Antiviral Active against Zika Virus |
| Q30145653 | Selective Activation of Type II Interferon Signaling by Zika Virus NS5 Protein |
| Q90205634 | Serologic Tools and Strategies to Support Intervention Trials to Combat Zika Virus Infection and Disease |
| Q38708263 | Single-Round Infectious Particle Antiviral Screening Assays for the Japanese Encephalitis Virus |
| Q51336279 | Smartphone-Based Mobile Detection Platform for Molecular Diagnostics and Spatiotemporal Disease Mapping. |
| Q43046666 | Specific detection of dengue and Zika virus antibodies using envelope proteins with mutations in the conserved fusion loop |
| Q40056291 | Structural Basis of Zika Virus-Specific Antibody Protection |
| Q26970833 | Structural basis of Zika virus helicase in recognizing its substrates |
| Q40037585 | Structural investigation of C6/36 and Vero cell cultures infected with a Brazilian Zika virus |
| Q58571068 | Structure analysis and antiviral activity of CW-33 analogues against Japanese encephalitis virus |
| Q29365369 | Structure and function of the Zika virus full-length NS5 protein |
| Q27928070 | Structures of NS5 Methyltransferase from Zika Virus |
| Q47555900 | Sustained specific and cross-reactive T cell responses to Zika and Dengue viruses NS3 in West Africa |
| Q46518619 | T Cell Immunity to Zika and Dengue Viral Infections |
| Q56345463 | Testicular degeneration and infertility following arbovirus infection |
| Q66679495 | The E3 ligase TRIM56 is a host restriction factor of Zika virus and depends on its RNA-binding activity but not miRNA regulation, for antiviral function |
| Q27924226 | The FDA-approved drug sofosbuvir inhibits Zika virus infection |
| Q24367663 | The IFITMs Inhibit Zika Virus Replication |
| Q61053694 | The Nucleotide Sensor ZBP1 and Kinase RIPK3 Induce the Enzyme IRG1 to Promote an Antiviral Metabolic State in Neurons |
| Q57789690 | The Small-Compound Inhibitor K22 Displays Broad Antiviral Activity against Different Members of the Family Flaviviridae and Offers Potential as a Panviral Inhibitor |
| Q47229433 | The Zika virus envelope protein glycan loop regulates virion antigenicity |
| Q37716454 | The conformational changes of Zika virus methyltransferase upon converting SAM to SAH. |
| Q24332542 | The crystal structure of Zika virus helicase: basis for antiviral drug design |
| Q90020206 | The journey of Zika to the developing brain |
| Q27924714 | The many faces of the flavivirus NS5 protein in antagonism of type I interferon signaling |
| Q56476829 | Tick-Borne Flaviviruses and the Type I Interferon Response |
| Q47557905 | To Zika and destroy: an antimalarial drug protects fetuses from Zika infection |
| Q90393978 | Topology, Antiviral Functional Residues and Mechanism of IFITM1 |
| Q64263739 | Vaccination With a Single Consensus Envelope Protein Ectodomain Sequence Administered in a Heterologous Regimen Induces Tetravalent Immune Responses and Protection Against Dengue Viruses in Mice |
| Q38157833 | Vaccine Mediated Protection Against Zika Virus-Induced Congenital Disease |
| Q26699951 | Vaginal Exposure to Zika Virus during Pregnancy Leads to Fetal Brain Infection |
| Q26747237 | Vertical Transmission of Zika Virus in Aedes aegypti Mosquitoes |
| Q50351020 | Vertical Transmission of the Zika Virus Causes Neurological Disorders in Mouse Offspring. |
| Q33860964 | Viperin is an important host restriction factor in control of Zika virus infection |
| Q47555854 | Viperin restricts Zika virus and tick-borne encephalitis virus replication by targeting NS3 for proteasomal degradation |
| Q90053557 | Virus Like Particles (VLP) as multivalent vaccine candidate against Chikungunya, Japanese Encephalitis, Yellow Fever and Zika Virus |
| Q38156841 | Virus-like particles that display Zika virus envelope protein domain III induce potent neutralizing immune responses in mice |
| Q28954575 | What to Expect When You’re Expecting Zika |
| Q41918357 | Zika Virus Encoding Non-Glycosylated Envelope Protein is Attenuated and Defective in Neuroinvasion |
| Q40037742 | Zika Virus Escapes NK Cell Detection by Upregulating Major Histocompatibility Complex Class I Molecules |
| Q24050115 | Zika Virus Infection during Pregnancy in Mice Causes Placental Damage and Fetal Demise |
| Q28733414 | Zika Virus Infects Early- and Midgestation Human Maternal Decidual Tissues, Inducing Distinct Innate Tissue Responses in the Maternal-Fetal Interface |
| Q24278525 | Zika Virus Infects Human Placental Macrophages |
| Q43046916 | Zika Virus Infects Intermediate Progenitor Cells and Post-mitotic Committed Neurons in Human Fetal Brain Tissues |
| Q43046795 | Zika Virus Replicates in Proliferating Cells in Explants from First-trimester Human Placentas, Potential Sites for Dissemination of Infection |
| Q38156734 | Zika Virus Research Models |
| Q92313109 | Zika Virus Targeting by Screening Inhibitors against NS2B/NS3 Protease |
| Q24261402 | Zika Virus Targets Human STAT2 to Inhibit Type I Interferon Signaling |
| Q38158918 | Zika Virus as an Emerging Neuropathogen: Mechanisms of Neurovirulence and Neuro-Immune Interactions |
| Q89975746 | Zika Virus-Induction of the Suppressor of Cytokine Signaling 1/3 Contributes to the Modulation of Viral Replication |
| Q30235853 | Zika Virus: Transmission, Detection, Control, and Prevention |
| Q28804217 | Zika and chikungunya: mosquito-borne viruses in a changing world |
| Q24261398 | Zika crisis in Brazil: challenges in research and development |
| Q23320717 | Zika virus and neurologic autoimmunity: the putative role of gangliosides |
| Q28828225 | Zika virus causes testicular atrophy |
| Q55084472 | Zika virus crosses an in vitro human blood brain barrier model. |
| Q27787333 | Zika virus epidemic in Brazil. I. Fatal disease in adults: clinical and laboratorial aspects |
| Q29365253 | Zika virus genome biology and molecular pathogenesis |
| Q41918368 | Zika virus infection confers protection against West Nile virus challenge in mice |
| Q41918070 | Zika virus infection dysregulates human neural stem cell growth and inhibits differentiation into neuroprogenitor cells |
| Q47547752 | Zika virus infection in a pediatric patient with acute gastrointestinal involvement |
| Q61795507 | Zika virus infection in causes dermatological manifestations and confers protection against secondary infection |
| Q52596426 | Zika virus infection in immunocompetent pregnant mice causes fetal damage and placental pathology in the absence of fetal infection. |
| Q47215672 | Zika virus infection induces host inflammatory responses by facilitating NLRP3 inflammasome assembly and interleukin-1β secretion |
| Q28027604 | Zika virus is not thermostable: very effective virus inactivation during heat treatment (pasteurization) of human serum albumin |
| Q48105726 | Zika virus like particles elicit protective antibodies in mice |
| Q50020968 | Zika virus outbreak: a review of neurological complications, diagnosis, and treatment options. |
| Q24765944 | Zika virus – emergence, evolution, pathology, diagnosis, and control: current global scenario and future perspectives – a comprehensive review |
| Q26742229 | Zika virus — reigniting the TORCH |
| Q27010749 | Zika virus: An emergent neuropathological agent |
| Q24244835 | Zika virus: An update on epidemiology, pathology, molecular biology, and animal model |
| Q56343708 | Zika-Induced Male Infertility in Mice Is Potentially Reversible and Preventable by Deoxyribonucleic Acid Immunization |
| Q39520186 | Zika: A Missed Opportunity to Protect Women's Health and Prevent Unwanted Pregnancies |
Search more.